Monument Therapeutics
About:
Monument Therapeutics develops products to treat serious diseases of the central nervous system.
Website: https://monumenttx.com/
Top Investors: Innovate UK, SyndicateRoom, O2h Ventures, Cambridge Angels group, Wren Capital
Description:
Monument Therapeutics is a biotechnology company intended to develop drugs to treat serious diseases of the central nervous system.
Total Funding Amount:
5.13M GBP
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Cambridge, Cambridgeshire, United Kingdom
Founded Date:
2019-01-01
Contact Email:
info(AT)monumenttx.com
Founders:
Number of Employees:
1-10
Last Funding Date:
2024-10-15
IPO Status:
Private
Industries:
© 2025 bioDAO.ai